Tradedoubler Interim Report January - June 2013 Stockholm,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tradedoubler Interim Report January - June 2013

Stockholm, 26 July 2013 On the road to recovery The second quarter April - June 2013 * Net sales amounted to SEK 490.3 M (573.7), a decrease of 10 per cent adjusted for changes in exchange rates. The anticipated volume drop in the non-strategic campaigns business continued during the second quarter, while the performance marketing segment showed continued positive development as the y/y revenue gap was reduced to 7 per cent, an improvement on the 11 per cent recorded in the first quarter. * Gross profit amounted to SEK 114.0 M (140.8). * EBITDA amounted to SEK 19.8 M (0.3), an increase of SEK 19.5 M. * Earnings per share, before and after dilution, increased to SEK 0.17 (- 0.25). The interim period January - June 2013 * Net sales amounted to SEK 1,018.2 M (1,213.9), a decrease of 12 per cent adjusted for changes in exchange rates. * Gross profit amounted to SEK 233.4 M (287.2). * EBITDA amounted to SEK 38.8 M (18.4), an increase of SEK 20.4 M. * Earnings per share, before and after dilution, increased to SEK 0.45 (- 0.02). Changed outlook for operating costs * The monthly cost run rate for operating costs before depreciation and amortisation during the second quarter stood on average at SEK 31.4 M, below the outlook given in the first quarter 2013 interim report, of approximately SEK 33.5 M. Tradedoubler anticipates that the costs during the remainder of 2013 will continue at the same level as during the interim period January - June, approximately SEK 32 M on average per month. For more information regarding outlook see page 9 in the report. Financial Apr-Jun Apr-Jun Jan-Jun Jan-Jun Full year overview, SEK M 2013 2012 Change %1 2013 2012 Change %1 2012 ------------------------------------------------------------------------------- Net sales 490.3 573.7 -10.0% 1,018.2 1,213.9 -12.1% 2,307.7 ------------------------------------------------------------------------------- Gross profit 114.0 140.8 -15.2% 233.4 287.2 -15.1% 541.5 as a percentage 23.2% 24.5% 22.9% 23.7% 23.5% of net sales ------------------------------------------------------------------------------- Total costs excluding -94.2 -140.5 -30.8% -194.6 -268.8 -25.4% -519.3 depreciation average per -31.4 -46.8 -32.4 -44.8 -43.3 month ------------------------------------------------------------------------------- EBITDA 19.8 0.3 - 38.8 18.4 178.2% 22.2 as a percentage 4.0% 0.0% 3.8% 1.5% 1.0% of net sales ------------------------------------------------------------------------------- Adjusted EBITDA2 19.8 9.8 155.3% 38.8 33.3 34.4% 53.3 as a percentage 4.0% 1.7% 3.8% 2.7% 2.3% of net sales ------------------------------------------------------------------------------- Operating profit 15.3 -2.8 - 30.2 9.9 447.0% 0.0 (EBIT) ------------------------------------------------------------------------------- Cash-flow from operating 17.2 -12.7 21.9 -21.8 -14.9 activities Net investments in intangible -8.2 -12.2 -16.3 -20.4 -36.2 assets ------------------------------------------------------------------------------- Earnings per 0.17 -0.25 0.45 -0.02 -0.24 share, SEK Cash-flow from operating 0.40 -0.30 0.52 -0.51 -0.35 activities per share, SEK ------------------------------------------------------------------------------- Return on equity 1.9 10.7 1.9 10.7 -1.9 (12 months) (%) ------------------------------------------------------------------------------- 1 Per cent changes are adjusted for changes in exchange rates 2 Adjusted for change-related costs in 2012 Presentation This interim report will be presented at a press and analyst conference call on 26th of July 2013 at 10.00 a.m. CET. To attend the conference call, please dial (SE) +46 8 505 56481, (UK) +44 20 336 45373 or (US) +1 877 788 9023. The presentation may also be followed via webcast using the link: http://financials.tradedoubler.com/en-gb/investorrelations Other information Tradedoubler discloses the information provided herein pursuant to the Swedish Securities Markets Act. The information was released for publication on 26th of July 2013 at 08.00 a.m. CET. The Group's numbers in this interim report are recognised excluding discontinued operations unless otherwise stated. Numerical data in brackets refers to the corresponding period in 2012 unless otherwise stated. Rounding off differences may arise. [HUG#1718970]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ovation's Roadmap for Revitalizing Rural Healthcare

Updated Category News Views 5

Steering Rural Healthcare Towards a Brighter Future Alright, here we are with Ovation Healthcare trying to inject some much-needed life into the sometimes forgotten corners of the healthcare world—those rural hospitals. They’ve cooked up a fresh white paper, and it’s got the makings of a lifeline for these institutions swirling in red ink. The financial landscape...

Continue Reading
ProperHeir Expands with New Innovative Office Space

Updated Category News Views 194

ProperHeir Expands with New Innovative Office Space ProperHeir has recently announced an exciting development with the opening of its new office at the Miramar Tech Center. This expansion marks a significant milestone as the company has tripled its available space. The chief purpose of this new office is to effectively host its growing in-house sales team and provide a...

Continue Reading
Discover How Octa Transforms Forex Trading for Singaporeans

Updated Category News Views 95

Understanding the Forex Market The foreign exchange market, commonly known as forex, stands as the largest and most dynamic financial market in the world. It allows traders to buy and sell currencies, leveraging the fluctuations in exchange rates to boost their earnings. Operating continuously from Monday to Friday, this market presents individual traders with the chance...

Continue Reading
Seoul Business Agency Powers Startups at the CES 2026 Pavilion

Updated Category News Views 176

Seoul Business Agency Showcases Startups at CES 2026 Pavilion The Seoul Business Agency (SBA) has taken ambitious strides to support the innovative spirit of Seoul's startups at CES 2026. Engaging with 19 prestigious institutions within Seoul’s ecosystem, the SBA is dedicated to empowering 70 startups as they venture onto the global stage. The 'Seoul POP' themed...

Continue Reading
VYJUVEK® Receives Groundbreaking Approval for DEB Treatment

Updated Category News Views 252

VYJUVEK® Approved for Dystrophic Epidermolysis Bullosa Treatment VYJUVEK approved for DEB treatment from birth, offering flexible home administration options for patients and their families. This breakthrough marks VYJUVEK as the first genetic medicine approved in Japan for DEB. Recently, Krystal Biotech, Inc. (NASDAQ: KRYS) announced that its innovative treatment,...

Continue Reading